Results 201 to 210 of about 6,575 (222)

Neuropsychopharmacological properties of novel melatonin MT1 receptor ligands

European Neuropsychopharmacology, 2017
S. Comai, L. Posa, R. Ochoa-Sanchez, G. Spadoni, G. Gobbi   +4 more
openaire   +1 more source

Microglial MT1 activation inhibits LPS‐induced neuroinflammation via regulation of metabolic reprogramming

Aging Cell, 2021
Guang-Hui Wang, Chun-Feng Liu
exaly  

Melatonin Receptor MT1 and MT2

2016
Atsuro Oishi, Ralf Jockers
openaire   +1 more source

Melatonin Receptor MT1

2018
openaire   +1 more source

MT1-MMP-Deficient Mice Develop Dwarfism, Osteopenia, Arthritis, and Connective Tissue Disease due to Inadequate Collagen Turnover

Cell, 1999
Kenn Holmbeck, Paolo Bianco, Pamela Robey   +2 more
exaly  

MT1 Melatonin Receptor

2018
openaire   +1 more source

Extracellular Matrix Proteolysis by MT1-MMP Contributes to Influenza-Related Tissue Damage and Mortality

Cell Host and Microbe, 2016
Inna Solomonov, Eyal David, Hadas Keren-Shaul   +2 more
exaly  

MT1-MMP proinvasive activity is regulated by a novel Rab8-dependent exocytic pathway

EMBO Journal, 2007
Diego Megias, Alicia G Arroyo, María C Montoya   +2 more
exaly  

Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion

EMBO Journal, 2001
Yoshifumi Itoh, Motoharu Seiki
exaly  

High-affinity peptide against MT1-MMP for in vivo tumor imaging

Journal of Controlled Release, 2011
Lei Zhu, Lin Wang, Ye Wang
exaly